Valuation: Nestmedic S.A.

Market Cap 35.19M 8.89M 7.97M 7.29M 6.66M 12.57M 834M 12.93M 87.91M 446M 33.34M 32.64M 1.41B P/E 2024
-2.96x
P/E 2025 -5.75x
Enterprise Value 36.02M 9.1M 8.16M 7.46M 6.81M 12.87M 854M 13.24M 89.98M 456M 34.13M 33.41M 1.44B EV / Sales 2024
22.3x
EV / Sales 2025 36.1x
Free-Float
45.56%
Yield 2024 *
-
Yield 2025 -
1 day+1.60%
1 week-1.55%
Current month-1.55%
1 month-3.64%
3 months-9.92%
6 months-3.64%
Current year-7.83%
1 week 0.6
Extreme 0.6
0.65
1 month 0.6
Extreme 0.6
0.7
Current year 0.49
Extreme 0.49
0.86
1 year 0.49
Extreme 0.49
0.86
3 years 0.39
Extreme 0.39
1.44
5 years 0.39
Extreme 0.39
2.9
10 years 0.39
Extreme 0.39
17.99
Manager TitleAgeSince
Chief Executive Officer - -
Chief Administrative Officer - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member 35 15/07/2019
Director/Board Member 55 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.60%-1.55%-14.05%-53.24% 8.93M
+2.63%-0.32%+22.75%+52.69% 257B
-3.36%+4.81%-17.34%+63.31% 157B
+1.73%-0.85%+9.29%+17.76% 162B
-4.23%+1.83%-56.84%-19.05% 61.96B
+1.31%+11.01%+23.90%+52.22% 58.73B
-0.76%+4.13%+0.84%-6.12% 55.42B
-2.05%-2.95%+4.30%+54.85% 49.18B
+1.73%-0.06%+18.49%+62.52% 49.27B
+1.00%-1.11%+23.29%+81.48% 44.96B
Average -0.04%+1.48%+1.46%+30.64% 89.59B
Weighted average by Cap. +0.26%+1.20%+5.29%+41.71%

Financials

2024 2025
Net sales 969K 245K 220K 201K 183K 346K 22.98M 356K 2.42M 12.28M 918K 899K 38.85M 846K 214K 192K 175K 160K 302K 20.07M 311K 2.11M 10.73M 802K 785K 33.92M
Net income -5.38M -1.36M -1.22M -1.11M -1.02M -1.92M -128M -1.98M -13.44M -68.19M -5.1M -4.99M -216M -4.6M -1.16M -1.04M -953K -870K -1.64M -109M -1.69M -11.49M -58.29M -4.36M -4.27M -184M
Net Debt 4.11M 1.04M 930K 851K 776K 1.47M 97.33M 1.51M 10.26M 52.03M 3.89M 3.81M 165M 830K 210K 188K 172K 157K 296K 19.67M 305K 2.07M 10.52M 786K 770K 33.25M
Projected Income Statement - Annual - Nestmedic S.A.
Logo Nestmedic S.A.
Nestmedic SA is a Poland-based company engaged in the manufacture of medical diagnostic equipment. The Company focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures mother’s pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.
Employees
-
Date Price Change Volume
06/11/26 PLN 0.6360 +1.60% 2,221
05/11/26 PLN 0.6260 0.00% 2,518
04/11/26 PLN 0.6260 -1.26% 6,529
03/11/26 PLN 0.6340 -1.86% 203
02/11/26 PLN 0.6460 0.00% 10,496